First Imaging, a Nantong-based medical imaging equipment provider, has closed a Series B+ financing round exceeding RMB 100 million (USD 14.5 million). The investment, led by Sichuan Development Hongke Private Equity Fund Management with participation from Softbank, Nanjing Jushi Venture Investment, and others, will accelerate market promotion of intelligent intraoperative imaging devices and digital consumables development, supporting the company’s “equipment + AI + ecosystem” strategy to transform surgical procedures from experience-driven to intelligence-driven.
Financing Overview
Element
Detail
Company
First Imaging (Nantong-based)
Round
Series B+
Amount Raised
>RMB 100 million (USD 14.5 million)
Lead Investor
Sichuan Development Hongke Private Equity Fund Management
Other Investors
Softbank, Nanjing Jushi Venture Investment, and more
Use of Proceeds
Intelligent intraoperative imaging market promotion; digital consumables R&D
Next-generation 3D imaging; AI algorithm enhancement; digital consumables portfolio
2026-2028
Ecosystem Building
Surgical data platform; remote consultation capabilities; training and education programs
2027+
Regulatory Expansion
NMPA Class III device approvals; CE Mark and FDA pathway evaluation
2026-2028
Forward‑Looking Statements This brief contains forward‑looking statements regarding First Imaging’s market expansion, AI-powered surgical platform adoption, and digital consumables commercialization. Actual results may differ due to hospital procurement cycle variability, competitive responses from multinational medtech giants, and regulatory approval timelines for AI-enabled medical devices.-Fineline Info & Tech